CN104323966A - Golden hydrotherapy composition and using method thereof - Google Patents
Golden hydrotherapy composition and using method thereof Download PDFInfo
- Publication number
- CN104323966A CN104323966A CN201410624272.9A CN201410624272A CN104323966A CN 104323966 A CN104323966 A CN 104323966A CN 201410624272 A CN201410624272 A CN 201410624272A CN 104323966 A CN104323966 A CN 104323966A
- Authority
- CN
- China
- Prior art keywords
- parts
- gold
- weight
- following component
- drating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 13
- 238000002169 hydrotherapy Methods 0.000 title abstract description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 58
- 229910052737 gold Inorganic materials 0.000 claims abstract description 58
- 239000010931 gold Substances 0.000 claims abstract description 58
- 239000011550 stock solution Substances 0.000 claims abstract description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 18
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 18
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 18
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 241000237858 Gastropoda Species 0.000 claims abstract description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 45
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 29
- 230000002421 anti-septic effect Effects 0.000 claims description 16
- 241000251468 Actinopterygii Species 0.000 claims description 15
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 12
- 239000000080 wetting agent Substances 0.000 claims description 12
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 claims description 11
- 229960001083 diazolidinylurea Drugs 0.000 claims description 11
- CZMOVKLQUFOJAZ-UHFFFAOYSA-N butyl n-(3-iodoprop-1-ynyl)carbamate Chemical compound CCCCOC(=O)NC#CCI CZMOVKLQUFOJAZ-UHFFFAOYSA-N 0.000 claims description 10
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 10
- 239000002562 thickening agent Substances 0.000 claims description 8
- 229920001577 copolymer Polymers 0.000 claims description 6
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 235000014676 Phragmites communis Nutrition 0.000 claims description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 229940049638 carbomer homopolymer type c Drugs 0.000 claims description 2
- 229940043234 carbomer-940 Drugs 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 229940068977 polysorbate 20 Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 18
- 239000002537 cosmetic Substances 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 241000252229 Carassius auratus Species 0.000 abstract 1
- 238000005282 brightening Methods 0.000 abstract 1
- 238000005562 fading Methods 0.000 abstract 1
- 230000008470 skin growth Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 101
- 210000004027 cell Anatomy 0.000 description 32
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 16
- 241000863032 Trieres Species 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 14
- 102000008186 Collagen Human genes 0.000 description 10
- 108010035532 Collagen Proteins 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 230000037303 wrinkles Effects 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 239000000049 pigment Substances 0.000 description 9
- 230000003266 anti-allergic effect Effects 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- 210000002615 epidermis Anatomy 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 230000003020 moisturizing effect Effects 0.000 description 7
- 102400001368 Epidermal growth factor Human genes 0.000 description 6
- 101800003838 Epidermal growth factor Proteins 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 229940116977 epidermal growth factor Drugs 0.000 description 6
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 6
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- 108010014258 Elastin Proteins 0.000 description 4
- 102000016942 Elastin Human genes 0.000 description 4
- 206010016807 Fluid retention Diseases 0.000 description 4
- 208000003351 Melanosis Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 229920002549 elastin Polymers 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 229920006243 acrylic copolymer Polymers 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 3
- -1 glyceryl acrylate Chemical compound 0.000 description 3
- 230000008676 import Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 description 2
- 241000881711 Acipenser sturio Species 0.000 description 2
- 208000037259 Amyloid Plaque Diseases 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 2
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 2
- 244000183278 Nephelium litchi Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000234609 Portulaca oleracea Species 0.000 description 2
- 235000001855 Portulaca oleracea Nutrition 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 238000010612 desalination reaction Methods 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000002570 interstitial cell Anatomy 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000036561 sun exposure Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- NIELXDCPHZJHGM-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NIELXDCPHZJHGM-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000009849 Cucumis sativus Nutrition 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 102000001301 EGF receptor Human genes 0.000 description 1
- 108060006698 EGF receptor Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 235000015742 Nephelium litchi Nutrition 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 108010076039 Polyproteins Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003560 epithelium corneal Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000010501 heavy metal poisoning Diseases 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229940116978 human epidermal growth factor Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229940089468 hydroxyethylpiperazine ethane sulfonic acid Drugs 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 210000003456 pulmonary alveoli Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000002435 rhinoplasty Methods 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to the fields of cosmetic products and in particular relates to a golden hydrotherapy composition and a using method thereof. The golden hydrotherapy composition is prepared from the following components in parts by weight: 52-55 parts of wisdom golden water, 12-14 parts of gold introduction liquid, 6-7 parts of gold stock solution, 6-7 parts of thin skin growth promoting liquid, 6-7 parts of hyaluronic acid stock solution, 6-7 parts of black gold fish egg essence and 6-7 parts of snail protein stock solution. Compared with the prior art, the golden hydrotherapy composition has remarkable effects of fading and removing spots and is also capable of obviously increasing water content of skin and brightening whole skin color of a face.
Description
Technical field
The present invention relates to cosmetic field, particularly a kind of gold hydrotherapy compoistion and method of use.
Background technology
Hyperpigmentation in skin and make skin to occur the flecks such as brown, yellowish-brown, black, is referred to as skin splash, is generally divided into chloasma, freckle, butterfly spot, senile plaque, sunburn etc.
Chloasma, be a kind of betide face pigment anomaly metabolism, pigmented dermatosis.Be more common in middle-aged women, its main manifestations is the speckle that the yellowish-brown that size shape differs or grey black appear in face, is often symmetrically distributed in the positions such as volume, face, cheek, nose and upper lip, does not exceed skin, clear border, the course of disease is slow, long-term existence, and the several years does not move back, often increase the weight of after Exposure to Sunlight, main cause is female endocrine dyscrasia, and stress is large, external chemicals etc.
Freckle, is generally distributed in face easily by the region that sun exposure arrives, causes primarily of genetic cause.
Black speck, is also butterfly spot, concentrates on two cheeks, and look like a butterfly of launching, main cause is excessive ultraviolet radiation, and skin irriate causes the increment of skin bottom melanocyte, produces too much melanin, forms black speck.
Senile plaque, a kind of geroderma pathological changes, is medically called seborrhoic keratosis.
Sunburn is after sunlight excessive radiation, skin generation erythema, edema, the cutaneous pigmentation occurred afterwards.
Except these mottles, also have some other mottle, as due to life-time service mercury cosmetic, cause skin to turn black, be called hydrargyrum speckle; Cyasma etc. is produced due to pregnancy.
Be below the method for common several speckle dispelling:
(1) spend hydrargyrum speckle cosmetics speckle dispelling, within the extremely short time, make whiteness of skin, once stop using, skin becomes more black immediately, and pigment rebounds, and wrinkle is deepened.Reason is that speckle cosmetics often with the addition of the lead, hydrargyrum etc. that exceed standard to human body skin, material that nervous system is poisonous, the heavy metal ion such as lead, hydrargyrum can act on the tryrosinase in melanin generative process, make it lose activity, thus prevent the formation of mottle, allow whiteness of skin.But this effect is of short duration, the consequence finally caused is tryrosinase or the unrestrictedly melanic generation of catalysis, makes skin darkening, and pigment rebounds, and even occurs heavy metal poisoning speckle.
(2) use laser beautifying to remove speckle, mainly utilize laser therapeutic apparatus to send specific wavelength, the laser of different wave length can by color special in skin or pigment absorption, and after pigment is gradually by body absorption, the color relation of mottle can be thereupon thin out.But laser goes speckle to be rely on external force " mandatory remove speckle " after all, can not block the generation of speckle from source.
(3) use fruit acid to change skin and remove speckle, selected fruit acid is the acid naturally of extracting from fruit, generally has moist effect lower than the low concentration fruit acid formula of 10%, skin can be made careful full of elasticity; Fruit acid higher than 20% then makes the outer aged cells of skin easily come off, and promotes the hypertrophy of collagen fiber in skin corium, sticky polyprotein simultaneously, can reach the effect of hydrargyrum speckle.Fruit acid changes skin and goes speckle can remove the speckle being positioned at epiderm skin shallow-layer, but then helpless to the pigment spot being positioned at epiderm skin deep layer (basal layer) or skin corium.In addition, utilize fruit acid to change skin and go the requirement of speckle high, first want rigorous aseptic to control; Secondly owing to adopting high concentration fruit acid, inevitably injure keratodermatitis, the function making skin resist extraneous infringement reduces, and also makes skin excessive water lose simultaneously, very easily occurs aging.
Summary of the invention
The object of the invention is to provide a kind of gold drating care composition, the above-mentioned technical problem existed with the method solving existing speckle dispelling.
Another object of the present invention is to provide the using method of above-mentioned gold drating care composition, the above-mentioned technical problem existed with the method solving existing speckle dispelling.
The object of the invention is realized by following technical scheme:
A kind of gold drating care composition, comprises the following component with parts by weight:
Preferably, described wisdom golden water comprises the following component with parts by weight:
Preferably, described wetting agent comprises the following component with parts by weight:
Glycerol 4-7 part;
PEG-4000 3-6 part;
Hyaluronate sodium 0.03-0.07 part;
Described antiseptic is methyl hydroxybenzoate;
Described thickening agent is carbomer.
As follows to the functional interpretation of some components of wisdom golden water:
Sturgeon roe beans extract: containing the basic fatty acid of the trace element needed for skin, mineral salt, protein, aminoacid and restructuring.Effectively can not only moisten skin nutrition, more have the effect making skin fine and smooth and bright and clean.
Beta glucan: can stimulating expression of macrophage, activating immune system, produces the cytokine promoting wound healing, Cell protection; There is anti-allergic effects, scytitis and tissue edema can be eliminated; The immunocompetence of damaged cell can be improved; Promote the synthesis of collagen protein and the division growth of Skin Cell; There is potent moisture-retaining capacity, improve the moist degree of skin cell, make the fine and smooth high resilience of skin gloss.
Triethanolamine: play neutralization.
Allantoin: play maintenance effect.
EDTA-disodium: play chelation.
Glycyrrhizic acid dipotassium: play anti-allergic effects.
Preferably, described gold importing liquid comprises the following component with parts by weight:
Preferably, described wetting agent comprises the following component with parts by weight:
Glycerol 1-4 part;
Polysorbate-20 0.3-0.6 part;
Hyaluronate sodium 0.03-0.05 part;
Described antiseptic comprises the following component with parts by weight:
Methyl hydroxybenzoate 0.08-0.2 part;
Diazolidinyl urea 0.1-0.3 part.
Functional interpretation gold being imported to some components of liquid is as follows:
Chitosan: deep moisturizing.
Fructus Cucumidis sativi (CUCUMIS SATIVUS) extract: moisturizing, maintenance, whitening.
Radix Glycyrrhizae (GLYCYRRHIZA URALENSIS) extract: antiallergic, maintenance.
Preferably, described gold stock solution comprises the following component with parts by weight:
Preferably, described wetting agent comprises the following component with parts by weight:
Propylene glycol 5-10 part;
Polyglycerolmethacrylate and PVA/MA copolymer 3-5 part; The compound that described polyglycerolmethacrylate and PVA/MA copolymer are made up of glycerol acrylate and PVA/MA copolymer.
Hyaluronate sodium 0.08-0.15 part;
Described thickening agent is Carbomer-940;
Described antiseptic comprises the following component with parts by weight:
Methyl hydroxybenzoate 0-0.3 part;
Diazolidinyl urea 0.1-0.3 part.
As follows to the functional interpretation of some components of gold stock solution:
Herba Portulacae (PORTULACA OLERACEA) extract: antiallergic of releiving.
Radix Glycyrrhizae (GLYCYRRHIZA URALENSIS) extract: antiallergic, maintenance.
Native gold: play anti-aging effects.
Preferably, described thin flesh growth-promoting media comprises the following component with parts by weight:
Preferably, described wetting agent comprises the following component with parts by weight:
Glycerol 5-10 part;
Hyaluronate sodium 0.1-0.3 part;
Described thickening agent is cellulose;
Described antiseptic is methyl hydroxybenzoate.
As follows to the functional interpretation of some components of thin flesh growth-promoting media:
Biological carbohydrate gum-2: moisturizing, antiinflammatory.
Oligopeptide (EGF epidermal growth factor) has following function:
(1) skin care effect: epidermal growth factor can irritate the various cells of ectoderm and endodermal origin as corneal epithelium and endotheliocyte, epidermis, skin corium cell (as fibroblast), mammary gland alveolus and Interstitial cell etc., make its proliferation apoptosis, accelerate metabolism, reach the effect of skin care.
(2) skin care: EGF can promote the biosynthesis of DNA, RNA and functional protein, the macromolecular synthesis in extracellular (as hyaluronic acid, elastic fiber albumen etc.) can be promoted, increase moisture content of skin, and then increase skin elasticity, Glycerin, recombinant human epidermal growth factor.
(3) smooth away wrinkles: epidermal growth factor promotes that cytotrophy material is initiatively transported in cell from extracellular, increases intracellular nutrition.Promote the functional moleculars such as skin corium emiocytosis rubber polymer fibril, polysaccharide, glycoprotein, make that subcutaneous dermal tissue is full, muscle fiber marshalling tight, thus reduce and smooth away wrinkles.
(4) wound is repaired: enter cell division cycle by irritating epidermis cell (comprising epithelial cell, various Interstitial cell that Various Tissues is originated) with EGF receptors bind, some critical function gene activations, expression, secretion biological activity protein etc. in active cell.Impel collagen fiber to be the linear alignment, the growth of epidermis cell fast regular is timely flap coverage also.After obvious acceleration beauty treatment, cosmetology and the wound healing such as other skin trauma, and keep wound surface flat smooth, abnormal pigmentary deposit on the skin trace is reduced or disappears and reduce pigmentation.
(5) mottle is prevented: the propagation of epidermal growth factor to epidermis cell has stronger facilitation, use rear youthening of epidermis cell, make the less accumulation such as residual having pigment and dead cell in epidermal tissue, cutaneous manifestations is gone out tenderly to have no time in vain, eliminate the performance of the abnormal skin such as mottle and pigmentation.Use EGF effectively can contain the recurrence of mottle in treatment phase of speckle dispelling and convalescent period.
Polypeptide-11 (AFG acid fibroblast growth factor):
The reparation of the fresh wound surface of (eyebrow tattooing, drift lip, augmentation rhinoplasty, wash eyebrow, cut informer) after contributing to plastic aesthetic surgery; Contribute to the quick reparation of the fresh wound surface such as burn, scratch, scald, traumatic injury; Contribute to red blood streak, speckle dispelling and the reparation of damaged skin after changing skin; Contribute to improving by sun exposure and abuse skin rubefaction that devalued cosmetic and environmental pollution cause, desquamation, the skin symptom such as thinning, responsive; Contribute to improving skin senilism, sallow, wrinkle, the phenomenon such as lax; Contribute to improving pachylosis, climate change makes xerosis cutis, desquamation, pruritus etc.; Contribute to improving skin sallow, dark and gloomy unglazed etc.; After contributing to photon delicate skin, the quick perfection of damaged skin is repaired; Can anti-acne, acne of dispelling, blackhead of dispelling, acne rosacea, soft skin; The perfect succedaneum of the daily nursing of any skin quality, moisturizing, cosmetics.
Heparin: antiinflammatory, antiallergic.
Preferably, described hyaluronic acid stock solution comprises the following component with parts by weight:
Water 90-99 part;
Hyaluronate sodium 0.5-1.0 part;
Antiseptic 0.2-0.6 part.
Preferably, described antiseptic comprises the following component with parts by weight:
Methyl hydroxybenzoate 0.1-0.3 part;
Diazolidinyl urea 0.1-0.3 part.
As follows to the functional interpretation of some components of hyaluronic acid stock solution:
Hyaluronic acid (being called for short HA): the water retention of HA in skin histology is one of its most important physiological function, and its theoretical water retention value is up to 500 milliliters/more than g, and the actual water retention value in connective tissue is about 80 milliliters/g.HA is when higher concentration, and its long strand mutually twists and is made into netted, in addition with the hydrogen bonded of water, thus plays very strong water retention.The Main Function of HA in intercellular substance (substrate) keeps moisture, with other sulphation mucopolysaccharide and the fibrous proteins such as collagen protein, elastin laminin, common composition, containing the outer gelatinised matrix of born of the same parents of large quantity of moisture, becomes the mass exchange medium of cellular metabolism.This moisture gelatinised matrix, makes that skin is pliable and tough, high resilience, and sufficient moisture makes the smooth delicacy of skin.When the moist feeling of skin disappears, when there is wrinkle, someone thinks and to cause due to the minimizing of HA.With advancing age, in skin, the content of HA reduces, and skin tissue cell and intercellular moisture reduce, the space that the intercellular gelatinised matrix that is main composition with HA is filled reduces, and cause cell arrangement tight, collagen protein dehydration is hardened, make pachylosis, follow the string.Therefore moisture is vital for skin health.Water conservation moisturizing is one of skin protection cosmetics (skin care cosmetics) topmost research topic always, is also one of main function of skin care item.
Preferably, described dark fund fish roe essence comprises the following component with parts by weight:
Preferably, described wetting agent comprises the following component with parts by weight:
Described antiseptic is diazolidinyl urea/iodo propinyl butyl carbamate/propylene glycol.
The compound that described glycerol/glyceryl acrylate/acrylic copolymer/propylene glycol/Gantrez AN-119 is made up of glycerol, glyceryl acrylate, acrylic copolymer, propylene glycol and Gantrez AN-119.
The compound that described AVC is made up of ammonium acryloyldime-thyltaurate and VP copolymer.
The compound that described diazolidinyl urea/iodo propinyl butyl carbamate/propylene glycol is made up of diazolidinyl urea, iodo propinyl butyl carbamate and propylene glycol.
As follows to the functional interpretation of some components of dark fund fish roe essence:
Fructus Litchi (LITCHI CHINENSIS) seed extract: free radical resisting.
Radix Malvae sylvestris (MALVA SYLVESTRIS) extract: antiallergic, has effect of releiving, replenishing collagen, recovers elasticity of skin.
Sturgeon roe beans extract: containing the basic fatty acid of the trace element needed for skin, mineral salt, protein, aminoacid and restructuring.Effectively can not only moisten skin nutrition, more have the effect making skin fine and smooth and bright and clean.
Cer EOS: repair barrier, defying age.
Preferably, described snail protein stock solution comprises the following component with parts by weight:
Preferably, described antiseptic is two imidazolidinyl urea/iodo propinyl butyl carbamate/propylene glycol; The compound that described pair of imidazolidinyl urea/iodo propinyl butyl carbamate/propylene glycol is made up of two imidazolidinyl urea, iodo propinyl butyl carbamate and propylene glycol.
Described wetting agent comprises the following component with parts by weight:
1,3 butanediol 8-15 parts;
Reed fragrant plant glue 3-6 part;
Hyaluronate sodium 0.08-0.15 part;
Described thickening agent is hydroxyethyl-cellulose.
As follows to the functional interpretation of some components of dark fund fish roe essence:
Vegetable protein: the synthesis of replenishing collagen.
Snail extract: keep moisture, keeps the elastin laminin of skin histology, and when the age increases, skin follows the string generation wrinkle, suitably supplements elastin and can prevent wrinkle appearance ahead of time, and reduce the injury of ultraviolet to skin.Anti-inflammatory, irritates cell regeneration, has the effect of releiving, and can be used as skin emolliency agent and antioxidant.Make the viscose lipid on skin epidermis top layer soft, be beneficial to remove old cutin, accelerate cell regeneration, reduce wrinkle of skin and cicatrix, can also the colour of skin be removed obscure, the destruction of desalination mottle and opposing radical pair skin.
Palmitoyl tripeptide 3: be also copper peptides; Glycyl-L-histidyl--1B.The triplet molecule that palmitoyl tripeptide 3 is linked to be with two victory peptide bonds by three amino acids, effectively can stop a kind of nerve conduction of Acetylcholine material, have the effect relaxed one's muscles, improve dynamic wrinkle.
Herba Portulacae (PORTULACA OLERACEA) extracting solution: antiallergic of releiving.
Dimethyl siloxane copolyether PEG-17: defying age.
Hydroxyethyl piperazine ethanesulfonic acid: play whitening function.
Preferably, the following component with parts by weight is comprised:
This optimum ratio is for melanin hiding in cell, beat back that skin is obscure, mottle comprehensively, highlight lighten skin color, and open skin moisturizing, lock water, water storage, water delivery circular water replenishing kinetic energy, promote collagen protein generation etc., to reach accurate light speckle, comprehensively whitening and effect of moisture-keeping crease-shedding.The concrete function of each component is as follows:
Wisdom golden water: the regeneration capacity increasing damaged cell, promotes that skin collagen protein generates, and makes cell obtain sufficient nourishing, and impels skin corium to secrete more collagen fiber and elastic fiber, accelerate intracellular melanin simultaneously and discharge.
Gold imports liquid: help multiple elite to import skin bottom fast, promotes the absorbance of skin to nutrient and moisture, realizes dynamic moisturizing, to maximize performance product efficacy.
Gold stock solution: the degree of depth is releived, calm skin, improves skin condition susceptible, takes multiple skin-active factor infiltration skin, disintegrates melanin layer by layer, the shining bright colour of skin.
Thin flesh growth-promoting media: promote epidermal metabolic, repairs damaged cell, and enhancing skin resistance, more nourishing purification skin, thoroughly disintegrate remaining melanin and check melanin is newborn.
Hyaluronic acid stock solution: catch and grab water oxygen layer layer to skin depths conveying moisture, compose and support cell, tight lock cell moisture, efficient moisture-retention.
Snail protein stock solution: promote that elastin laminin generates, desalination wrinkle, and reduces the injury of ultraviolet to skin, prevents that the skin that causes because of illumination is obscure waits Aging symptom.
Dark fund fish roe essence: precisely repair pathological changes and senile cell, promotion cell melanin is discharged, reduction skin self repair ability, helps skin to take off black supporting in vain.
The using method of above-mentioned gold drating care composition, comprises the following steps:
Wisdom golden water 52-55 part, gold are imported liquid 12-14 part, gold stock solution 6-7 part, thin flesh growth-promoting media 6-7 part, hyaluronic acid stock solution 6-7 part, dark fund fish roe essence 6-7 part and snail protein stock solution 6-7 part and is mixed to form mixed liquor, and user is got appropriate mixed liquor and is applied on the face after washing one's face.
Compared with prior art, the present invention has following beneficial effect:
Gold drating care composition of the present invention Be very effective in light speckle, speckle dispelling, also can significantly improve the water content of skin simultaneously, highlights the overall colour of skin of face.
Detailed description of the invention
The present invention is described in detail below in conjunction with embodiment.
Below the source of some components that embodiment is used is specifically described.
Polyglycerolmethacrylate and PVA/MA copolymer are compound, and purchased from Shanghai Zhen Yuli economic trade development company limited, lot number is 20140320.Glycerol/glyceryl acrylate/acrylic copolymer/propylene glycol/Gantrez AN-119 is compound, and purchased from Shanghai Zhen Yuli economic trade development company limited, lot number is 20140320.Diazolidinyl urea/iodo propinyl butyl carbamate/propylene glycol is compound, and purchased from Shanghai Zhen Yuli economic trade development company limited, lot number is 140827.Two imidazolidinyl urea/iodo propinyl butyl carbamate/propylene glycol is compound, and purchased from Shanghai Zhen Yuli economic trade development company limited, lot number is 140827.AVC is compound, and purchased from Shanghai Zhi Rou trade Co., Ltd, lot number is ESD0900372.
All components in following examples all can commercially be bought.
Embodiment 1
A kind of gold drating care composition, comprises the following component with parts by weight:
Wherein, described wisdom golden water comprises the following component with parts by weight:
Described gold importing liquid comprises the following component with parts by weight:
Described gold stock solution comprises the following component with parts by weight:
Described thin flesh growth-promoting media comprises the following component with parts by weight:
Described hyaluronic acid stock solution comprises the following component with parts by weight:
Described dark fund fish roe essence comprises the following component with parts by weight:
Described snail protein stock solution comprises the following component with parts by weight:
Embodiment 2
A kind of gold drating care composition, comprises the following component with parts by weight:
Wherein, described wisdom golden water comprises the following component with parts by weight:
Described gold importing liquid comprises the following component with parts by weight:
Described gold stock solution comprises the following component with parts by weight:
Described thin flesh growth-promoting media comprises the following component with parts by weight:
Described hyaluronic acid stock solution comprises the following component with parts by weight:
Described dark fund fish roe essence comprises the following component with parts by weight:
Described snail protein stock solution comprises the following component with parts by weight:
Embodiment 3
A kind of gold drating care composition, comprises the following component with parts by weight:
Wherein, described wisdom golden water comprises the following component with parts by weight:
Described gold importing liquid comprises the following component with parts by weight:
Described gold stock solution comprises the following component with parts by weight:
Described thin flesh growth-promoting media comprises the following component with parts by weight:
Described hyaluronic acid stock solution comprises the following component with parts by weight:
Described dark fund fish roe essence comprises the following component with parts by weight:
Described snail protein stock solution comprises the following component with parts by weight:
The present invention also provides the using method of above-mentioned gold drating care composition, comprises the following steps:
Wisdom golden water 52-55 part, gold are imported liquid 12-14 part, gold stock solution 6-7 part, thin flesh growth-promoting media 6-7 part, hyaluronic acid stock solution 6-7 part, dark fund fish roe essence 6-7 part and snail protein stock solution 6-7 part and is mixed to form mixed liquor, and user is got appropriate mixed liquor and is applied on the face after washing one's face.
Effect experimental
1, the sex composition of trier
Totally 200 triers, wherein, women is 180, accounts for total number of persons 90%; Boy student is 20, accounts for total number of persons 10%.All there are dissimilar pigmented spots in the face of 200 triers.
2, the age composition of trier
In 200 triers, 20-25 year 50 people, 26-30 year 50 people, 31-35 year 50 people, more than 35 years old 50 people, respectively account for total number of persons 25%.
3, the time on probation
28 days
4, trial method
Wisdom golden water in embodiment 1, gold are imported liquid, gold stock solution, thin flesh growth-promoting media, hyaluronic acid stock solution, dark fund fish roe essence and snail protein stock solution and is mixed to form mixed liquor, gets appropriate mixed liquor after trier washes one's face every night and be applied on the face.
5, the data analysis after trying out
On probation after one week:
Before comparatively using, skin state is compared, and 95% trier's skin water content improves 20%-38%, and the overall colour of skin of 90% trier highlights 10%-20%, and 84% trier's observability pigmented spots are not improved;
On probation after two weeks:
Compare compared with first week result on trial, 50% trier's skin water content is compared and is improved 5%-10%, and the overall colour of skin of 70% trier highlights 5%-18%, and 87% trier's observability pigmented spots slightly subtract light;
On probation after three weeks:
Comparatively second week result on trial is compared, and 30% trier's skin water content is compared and improved 3%-8%, and the overall colour of skin of 80% trier highlights 5%-10%, and 76% trier's observability pigmented spots are obviously desalinated;
After surrounding on probation:
Compare compared with the 3rd week result on trial, 10% trier's skin water content is compared and is improved 1%-8%, and the overall colour of skin of 74% trier highlights 3%-8%, and 20% trier is without observability pigmented spots.
In the wisdom golden water, gold importing liquid, gold stock solution, thin flesh growth-promoting media, hyaluronic acid stock solution, dark fund fish roe essence and snail protein stock solution of gold drating care composition of the present invention, there is different active component separately, it is as follows that these become branch to interact: EGF epidermal growth factor acts on the impaired skin of epidermal cell repairing, the propagation of reinforcing stimulus epidermis cell, reduce the residual accumulation of pigment and waste and old cell in epidermal tissue, desalinate pigment cicatrix, speckle gradually; Hyaluronic acid stock solution is containing high concentration bimolecular hyaluronic acid effect skin skin corium: macromole is caught and grabbed water oxygen formation pole profit moisture film, to skin depths conveying moisture; Micromolecule efficiently imports water oxygen in the profit moisture film of pole, composes and supports cell, tight lock cell moisture; Deep-sea fish roe elite attacks skin basal layer directly, regenerative cell's vigor, supply multi-nutrition, and under EGF epidermal growth factor activates, cell is constantly updated and divided, and precisely repairs pathological changes and senile cell, promotes comprehensive foster flesh ability.Thus reach but the maintenance skin effect such as black de-black, promotion cell regeneration.
After wisdom golden water, gold are imported the mixing of liquid, gold stock solution, thin flesh growth-promoting media, hyaluronic acid stock solution, dark fund fish roe essence and snail protein stock solution, generally should be finished in 7 days.As loaded in mixture in advance, active component can react in bottle, and when person to be used uses, active component reduces, and no longer plays its effect, and then greatly reduces effect of product.
Be only several specific embodiments of the application above, but the application is not limited thereto, the changes that any person skilled in the art can think of, all should drops in the protection domain of the application.
Claims (17)
1. a gold drating care composition, is characterized in that, comprises the following component with parts by weight:
2. gold drating care composition as claimed in claim 1, it is characterized in that, described wisdom golden water comprises the following component with parts by weight:
3. gold drating care composition as claimed in claim 2, is characterized in that,
Described wetting agent comprises the following component with parts by weight:
Glycerol 4-7 part;
PEG-4000 3-6 part;
Hyaluronate sodium 0.03-0.07 part;
Described antiseptic is methyl hydroxybenzoate;
Described thickening agent is carbomer.
4. gold drating care composition as claimed in claim 1, is characterized in that, described gold importing liquid comprises the following component with parts by weight:
5. gold drating care composition as claimed in claim 4, is characterized in that,
Described wetting agent comprises the following component with parts by weight:
Glycerol 1-4 part;
Polysorbate-20 0.3-0.6 part;
Hyaluronate sodium 0.03-0.05 part;
Described antiseptic comprises the following component with parts by weight:
Methyl hydroxybenzoate 0.08-0.2 part;
Diazolidinyl urea 0.1-0.3 part.
6. gold drating care composition as claimed in claim 1, it is characterized in that, described gold stock solution comprises the following component with parts by weight:
7. gold drating care composition as claimed in claim 6, is characterized in that,
Described wetting agent comprises the following component with parts by weight:
Propylene glycol 5-10 part;
Polyglycerolmethacrylate and PVA/MA copolymer 3-5 part;
Hyaluronate sodium 0.08-0.15 part;
Described thickening agent is Carbomer-940;
Described antiseptic comprises the following component with parts by weight:
Methyl hydroxybenzoate 0-0.3 part;
Diazolidinyl urea 0.1-0.3 part.
8. gold drating care composition as claimed in claim 1, it is characterized in that, described thin flesh growth-promoting media comprises the following component with parts by weight:
9. gold drating care composition as claimed in claim 8, is characterized in that,
Described wetting agent comprises the following component with parts by weight:
Glycerol 5-10 part;
Hyaluronate sodium 0.1-0.3 part;
Described thickening agent is cellulose;
Described antiseptic is methyl hydroxybenzoate.
10. gold drating care composition as claimed in claim 1, it is characterized in that, described hyaluronic acid stock solution comprises the following component with parts by weight:
Water 90-99 part;
Hyaluronate sodium 0.5-1.0 part;
Antiseptic 0.2-0.6 part.
11. gold drating care composition as claimed in claim 10, it is characterized in that, described antiseptic comprises the following component with parts by weight:
Methyl hydroxybenzoate 0.1-0.3 part;
Diazolidinyl urea 0.1-0.3 part.
12. gold drating care composition as claimed in claim 1, is characterized in that, described dark fund fish roe essence comprises the following component with parts by weight:
13. gold drating care composition as claimed in claim 12, is characterized in that,
Described wetting agent comprises the following component with parts by weight:
Described antiseptic is diazolidinyl urea/iodo propinyl butyl carbamate/propylene glycol.
14. gold drating care composition as claimed in claim 1, it is characterized in that, described snail protein stock solution comprises the following component with parts by weight:
15. gold drating care composition as claimed in claim 14, is characterized in that,
Described antiseptic is two imidazolidinyl urea/iodo propinyl butyl carbamate/propylene glycol;
Described wetting agent comprises the following component with parts by weight:
1,3 butanediol 8-15 parts;
Reed fragrant plant glue 3-6 part;
Hyaluronate sodium 0.08-0.15 part;
Described thickening agent is hydroxyethyl-cellulose.
16., as the gold drating care composition in claim 1-15 as described in any one, is characterized in that, comprise the following component with parts by weight:
17. 1 kinds, as the using method of the gold drating care composition in claim 1-16 as described in any one, is characterized in that, comprise the following steps:
Wisdom golden water 52-55 part, gold are imported liquid 12-14 part, gold stock solution 6-7 part, thin flesh growth-promoting media 6-7 part, hyaluronic acid stock solution 6-7 part, dark fund fish roe essence 6-7 part and snail protein stock solution 6-7 part and is mixed to form mixed liquor, and user is got appropriate mixed liquor and is applied on the face after washing one's face.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410624272.9A CN104323966A (en) | 2014-11-06 | 2014-11-06 | Golden hydrotherapy composition and using method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410624272.9A CN104323966A (en) | 2014-11-06 | 2014-11-06 | Golden hydrotherapy composition and using method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104323966A true CN104323966A (en) | 2015-02-04 |
Family
ID=52398876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410624272.9A Pending CN104323966A (en) | 2014-11-06 | 2014-11-06 | Golden hydrotherapy composition and using method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104323966A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107714582A (en) * | 2017-10-31 | 2018-02-23 | 广州赛莱拉干细胞科技股份有限公司 | A kind of composition of anti-aging and the skin care item containing said composition |
| CN110200842A (en) * | 2019-05-14 | 2019-09-06 | 广州辰美化妆品有限公司 | Skin-care product additive |
| US20200100993A1 (en) * | 2018-06-14 | 2020-04-02 | Luxbiotech Farmaceutica Ltda | Use of revitalizing cosmetic composition and non-therapeutic methods |
| CN117045579A (en) * | 2023-09-12 | 2023-11-14 | 广州茵绢漫化妆品有限公司 | Moisturizing and anti-wrinkle essence and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1325674A (en) * | 2000-05-26 | 2001-12-12 | 天津市化妆品科学技术研究所 | Gold-contained cosmetics |
| CN1489454A (en) * | 2001-02-16 | 2004-04-14 | ���ط�ķ�ɷݹ�˾ | Cosmetically effective composition containing malva sylvestris and mentha piperita extracts |
| CN101601636A (en) * | 2009-05-12 | 2009-12-16 | 扬州大学 | A kind of hydrotherapy preparation and preparation method thereof |
| CN102440943A (en) * | 2011-08-25 | 2012-05-09 | 唯美度科技（北京）有限公司 | Composition for caring and improving aged or damaged skin |
| KR101262557B1 (en) * | 2011-11-08 | 2013-05-08 | 박정애 | Natural korean herb cosmetic |
| CN103860451A (en) * | 2014-04-01 | 2014-06-18 | 广东伊茗药业有限公司 | Functional skin care product containing snail mucus extractive and preparation method thereof |
-
2014
- 2014-11-06 CN CN201410624272.9A patent/CN104323966A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1325674A (en) * | 2000-05-26 | 2001-12-12 | 天津市化妆品科学技术研究所 | Gold-contained cosmetics |
| CN1489454A (en) * | 2001-02-16 | 2004-04-14 | ���ط�ķ�ɷݹ�˾ | Cosmetically effective composition containing malva sylvestris and mentha piperita extracts |
| CN101601636A (en) * | 2009-05-12 | 2009-12-16 | 扬州大学 | A kind of hydrotherapy preparation and preparation method thereof |
| CN102440943A (en) * | 2011-08-25 | 2012-05-09 | 唯美度科技（北京）有限公司 | Composition for caring and improving aged or damaged skin |
| KR101262557B1 (en) * | 2011-11-08 | 2013-05-08 | 박정애 | Natural korean herb cosmetic |
| CN103860451A (en) * | 2014-04-01 | 2014-06-18 | 广东伊茗药业有限公司 | Functional skin care product containing snail mucus extractive and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 田富饶，等: ""荔枝核在化妆品中的研究现状"", 《香料香精化妆品》 * |
| 郑世彬: "《首尔美妆品购物全书》", 31 March 2014, 中国轻工业出版社 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107714582A (en) * | 2017-10-31 | 2018-02-23 | 广州赛莱拉干细胞科技股份有限公司 | A kind of composition of anti-aging and the skin care item containing said composition |
| US20200100993A1 (en) * | 2018-06-14 | 2020-04-02 | Luxbiotech Farmaceutica Ltda | Use of revitalizing cosmetic composition and non-therapeutic methods |
| CN110200842A (en) * | 2019-05-14 | 2019-09-06 | 广州辰美化妆品有限公司 | Skin-care product additive |
| CN117045579A (en) * | 2023-09-12 | 2023-11-14 | 广州茵绢漫化妆品有限公司 | Moisturizing and anti-wrinkle essence and preparation method thereof |
| CN117045579B (en) * | 2023-09-12 | 2024-04-09 | 百特威(上海)化妆品有限公司 | Moisturizing and anti-wrinkle essence and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101686399B1 (en) | Cosmetic composition for anti-aging | |
| CN102293733B (en) | Overall whitening and speckle removal skin care product | |
| CN107875067B (en) | Skin care composition and use thereof | |
| CN103228263B (en) | For whitening and the cosmetic composition improving skin elasticity | |
| CN104173251B (en) | A kind of bone glue of yak former peptide cleawhite pack and preparation method thereof | |
| RU2492850C2 (en) | Fibroblast growth agent | |
| CN103565699B (en) | A kind of black Fructus Lycii freckle removing and whitening defying age essence and preparation method thereof | |
| JP2011516585A (en) | Skin care composition and method of use thereof | |
| CN110430865A (en) | Cosmetic composition and application thereof comprising Inonotus obliquus extract | |
| JP2023526854A (en) | Skin care products containing a protein matrix | |
| CN109172390A (en) | A kind of multiple-effect of the extract containing Ganoderma Sinense is preserved youthful looks lotion and preparation method thereof | |
| CN111135112A (en) | A kind of anti-wrinkle and anti-aging skin care composition and use thereof | |
| CN111888279B (en) | Method for promoting collagen production and corresponding medicine or cosmetic | |
| CN109833221A (en) | A kind of anti-ageing aging facial treatment milk of eye and preparation method thereof | |
| KR20150120426A (en) | Cosmetic composition containing a brown alga extract, a yeast extract and ascorbic acid | |
| CN103948525A (en) | Anti-aging active composition for epidermis | |
| CN104323966A (en) | Golden hydrotherapy composition and using method thereof | |
| CN109330954B (en) | Whitening skin brightening lotion, preparation method thereof and tyrosinase inhibitor | |
| KR101697152B1 (en) | Manufacturing method of cosmetic material having an anti-aging effect using mucin from eel skin | |
| CN103027868A (en) | Man wet tissue finishing liquor | |
| CN116115540B (en) | Skin anti-aging composition, application and daily chemical product | |
| CN108524354A (en) | Skin care compositions, facial treatment mask and preparation method thereof | |
| CN107551262A (en) | It is a kind of that there is anti-ageing, wrinkle removing effect formulation product | |
| CN108186438A (en) | A kind of after-sun gel containing Porcine HGF and preparation method thereof | |
| CN107496194A (en) | A kind of surfactant and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150204 |